NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AMS Planning

AMS Planning

Private
TokyoMedia, Entertainment & Gaminghttps://ams-plan.com/

Last Round

Private Equity

May 30, 2025

Total Funding Raised

$2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AMS Planning is a drug discovery company that develops nuclear medicine technologies designed to transform Japan's healthcare infrastructure by advancing clinical innovation and operational efficiency.

Sector

Media, Entertainment & Gaming

Verticals

Facility Management, HR, Project Management

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Non-AI

Keywords

arts and culture consultingfacility planningstrategic planningnon-profit consultingbusiness planningvenue planningentertainment industry consultingfinancial modelingperformance benchmarkingarts analyticscultural planningcommunity engagementorganizational developmentexecutive searchpublic policy consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMS Planning Comparables

Compare AMS Planning with similar companies based on industry and business-model similarity.

AMS Planning comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

AMS Planning Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMay 30, 2025
Series ANov 9, 2022

AMS Planning Investors

Notable investors and investment history

AMS Planning investors
InvestorRounds
MIRAISOZO INVESTMENTS Inc.Series A, Private Equity
Vision Incubate Co., Ltd.Private Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 291% MoM, reaching 1.1K.

  • Jan 8, 2026

    Monthly visitors grew 367% MoM, from 364 to 1.7K.

AMS Planning Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AMS Planning Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMS Planning's valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range5
Year Founded2019
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.